Molecule Details
| InChIKey | DOABBONQBBUCRN-IMDVACINSA-N |
|---|---|
| Compound Name | 3-{(S)-2-[2-tert-Butoxycarbonylamino-3-(1H-indol-3-yl)-propionylamino]-6-[3-(2-nitro-phenyl)-ureido]-hexanoylamino}-N-(1-carbamoyl-2-phenyl-ethyl)-succinamic acid |
| Canonical SMILES | CC(C)(C)OC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCNC(=O)Nc1ccccc1[N+](=O)[O-])C(=O)NC(CC(=O)O)C(=O)NC(Cc1ccccc1)C(N)=O |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 6.09 |
| Source | BindingDB;TTD_MultiTarget |
2D Structure
Activity Profile